﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>01</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Adipose derived mesenchymal stem cells and their role in management of kidney diseases</ArticleTitle>
    <FirstPage>e32244</FirstPage>
    <LastPage>e32244</LastPage>
    <ELocationID EIdType="doi">10.34172/jrip.2024.32244</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Farahnaz</FirstName>
        <LastName>Dadras</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0181-9080</Identifier>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Khoshjou</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1624-7879</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jrip.2024.32244</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>09</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>12</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Kidney diseases are universal and researchers are trying to figure out how to manage them. Meanwhile, stem cells are a promising source of therapy that has been considered for various kinds of illnesses. Here, we are going to present the newest studies allocated to the role of adipose-derived stem cells in the management of kidney diseases (e.g. acute and chronic kidney diseases, diabetic nephropathy, and rejection). By searching in PubMed, 34 paper related to the topic were reviewed. Various diseases and pathophysiologic aspects of them have been considered in their presentation, as well. Route of injection, combination therapy, and scaffolds are among the other subjects.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Adipose-derived mesenchymal stem cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Extracellular vesicles</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diabetic nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Nephrotoxicity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Renal ischemia</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>